Heart failure device remote monitoring has grown well beyond a single implant. Care teams can now choose from sensors placed in the pulmonary artery, algorithms built into defibrillators, and connected home devices like scales and blood pressure monitors. Each tracks a different early warning sign. Each fits a different patient.
This guide explains how the main types of heart failure devices work and what the latest research shows. It also covers Medicare coverage and how care teams decide which approach fits a given patient.
Heart Failure Device Remote Monitoring
Heart failure device remote monitoring is getting more attention because the condition keeps growing. About 7.7 million U.S. adults live with heart failure, roughly 3% of the adult population, according to the Heart Failure Society of America’s HF Stats 2026 report. Nearly one in four Americans will develop it during their lifetime. The same report found heart failure mortality rising, with younger adults seeing some of the sharpest increases.
Heart failure rarely worsens overnight. Pressure inside the heart and lungs often climbs days or weeks before a patient feels short of breath or notices swelling. By the time symptoms appear, a hospital stay can be hard to avoid.
That window is where monitoring helps. A device that picks up early changes gives clinicians time to adjust diuretics or other medications while the patient is still at home.
Implanted Pulmonary Artery Pressure Sensors
The most studied form of heart failure device remote monitoring is the implanted pulmonary artery (PA) pressure sensor. Rising PA pressure is one of the earliest signs of fluid buildup. It often shows up well before weight gain or symptoms.
CardioMEMS HF System
Abbott’s CardioMEMS sensor is about the size of a paperclip. A cardiologist places it in the pulmonary artery during a right heart catheterization. The sensor has no battery and no leads.
Once a day, the patient lies on a pillow with a built-in antenna. The pillow powers the sensor, captures the pressure reading in less than a minute, and sends it to the care team. Clinicians review the trend and adjust medications when pressures drift outside the patient’s target range.
The FDA first approved CardioMEMS in 2014 based on the CHAMPION trial. In 2022, the indication expanded to NYHA class II or III patients who were hospitalized for heart failure in the prior year or have elevated natriuretic peptides.
The evidence base has grown since then. Three randomized trials now support the device. CHAMPION and GUIDE-HF were run in North America. MONITOR-HF, published in The Lancet in 2023, tested the sensor in 348 patients across 25 centers in the Netherlands.
In MONITOR-HF, patients with the sensor gained about seven points on the Kansas City Cardiomyopathy Questionnaire, a standard quality-of-life measure. Scores in the control group fell. Heart failure hospitalizations dropped 44%. A pooled analysis of all three trials found a 30% lower risk of heart failure hospitalization with PA pressure-guided care.
Cordella PA Sensor System
In June 2024, the FDA approved Cordella, a second PA sensor developed by Endotronix. Edwards Lifesciences acquired Endotronix shortly after. Cordella is approved for NYHA class III patients.
Its design is worth noting. Cordella pairs the implanted sensor with a Bluetooth blood pressure cuff and scale. Clinicians see PA pressure next to weight, blood pressure, heart rate, and oxygen saturation in one view.
The PROACTIVE-HF trial enrolled 456 patients. Two-year results showed that more than two-thirds of patients had no heart failure hospitalizations during that time. A follow-on trial, PROACTIVE-HF 2, is studying the sensor in NYHA class II and III patients.
Cordella’s design makes one point clear. Even with an implanted sensor, home vitals still matter.
Cardiac Implantable Electronic Devices With Heart Failure Algorithms
Many heart failure patients already have an implantable cardioverter defibrillator (ICD) or a cardiac resynchronization therapy (CRT) device. Some of these devices also support heart failure device remote monitoring through built-in algorithms.
Boston Scientific’s HeartLogic is the best-known example. It combines several sensor readings into a single index. Inputs include heart sounds, chest impedance, breathing rate, night heart rate, and activity. When the index crosses a set threshold, the clinic gets an alert. Medtronic offers a similar tool called TriageHF.
Real-world results are encouraging. The HeartLogic France Cohort Study, published in November 2025 in the European Heart Journal: Digital Health, followed 309 patients for a year. Clinicians contacted patients when the index reached 16 and adjusted treatment as needed. Only 6.1% of patients had an unplanned heart failure hospitalization. Two-thirds of those hospitalizations were preceded by an alert.
The advantage is simple. No new procedure is needed. The limit is just as simple. These algorithms only help patients who already have a compatible device.
Connected Home Devices for Heart Failure
For most patients, heart failure device remote monitoring starts with devices that sit on a bathroom floor or kitchen table. Connected scales, blood pressure monitors, and pulse oximeters remain the foundation of remote patient monitoring (RPM) for heart failure. They need no procedure, and they work across every stage of the condition.
Connected Weight Scales
Daily weight is the classic early signal of fluid retention. Many heart failure care plans call for a check-in when a patient gains two to three pounds in a day or about five pounds in a week. A connected scale sends each reading automatically. The care team no longer depends on a paper log or a patient’s memory.
Blood Pressure Monitors
Blood pressure and heart rate guide medication titration. Readings that run low can signal that a dose increase should wait. Readings that run high may point to a different problem worth a closer look.
Pulse Oximeters
Oxygen saturation adds context when a patient reports shortness of breath. A falling reading alongside rising weight tells a clearer story than either number alone.
Why Connectivity Matters
How a device connects matters as much as what it measures. Cellular devices send readings without an app, a smartphone, or Wi-Fi. Bluetooth devices can do the same through a cellular hub like the Tenovi Gateway. Many heart failure patients are 65 and up or managing several conditions at once. Fewer setup steps usually lead to more consistent daily readings.
Tenovi’s review of cardiac care research at home covers the broader evidence behind these programs.
Comparing Heart Failure Devices for Remote Monitoring
| Device type | What it measures | Best fit | Procedure needed |
|---|---|---|---|
| PA pressure sensor (CardioMEMS, Cordella) | Pulmonary artery pressure | NYHA class II or III patients with recent hospitalization or elevated natriuretic peptides | Yes, catheter-based implant |
| ICD or CRT with heart failure algorithm (HeartLogic, TriageHF) | Combined index of heart sounds, impedance, breathing, heart rate, activity | Patients who already have a compatible device | No new procedure |
| Connected home devices | Weight, blood pressure, heart rate, oxygen saturation | Broad heart failure population, including after discharge | None |
How Care Teams Choose the Right Approach
No single device fits every patient. Choosing one usually comes down to a few questions. How advanced is the heart failure? Has the patient been hospitalized recently? Do they already have an ICD or CRT device? Can they reach a center that implants PA sensors? And what will they actually use every day?
Many programs layer these tools. A patient with a PA sensor still benefits from a daily weight. A patient with HeartLogic may still need blood pressure readings to titrate medications safely.
A device is only one part of the program. The other part is the care team that reviews readings and calls the patient. An alert helps only if someone acts on it the same day. Tenovi’s heart failure case report shows how one program caught a data error and kept a high-risk patient out of the hospital for nine months.
For more on program design and readmission research, see Tenovi’s guide to heart failure monitoring.
Medicare Coverage for Heart Failure Device Remote Monitoring
Medicare coverage for heart failure device remote monitoring has expanded in the last two years. In January 2025, CMS issued a national coverage determination (NCD 20.36) for implanted PA pressure sensors.
Coverage applies under Coverage with Evidence Development. That means patients are enrolled in a CMS-approved study. Eligible patients have had chronic heart failure for at least three months and are NYHA class II or III, regardless of ejection fraction. CMS approved studies for both CardioMEMS and Cordella in February 2025.
Ongoing monitoring of a PA sensor is reported with CPT 93264. Connected home devices fall under the standard RPM codes: CPT 99453, 99454, 99457, and 99458. The 2026 Physician Fee Schedule added CPT 99445 for 2 to 15 days of readings in a month. It also added CPT 99470 for the first 10 minutes of management time. These changes let programs keep supporting patients during months when daily readings are not clinically needed.
Reimbursement information is provided for educational purposes only and is not legal, compliance, billing, coding, or reimbursement advice. Coding, coverage, and payment vary by payer and locality and are subject to change. Coverage or payment is not guaranteed; consult applicable payer guidance and qualified advisors. CPT® is a registered trademark of the American Medical Association.
Heart Failure Device Remote Monitoring FAQs
These are the questions clinicians and program leaders ask most about heart failure device remote monitoring. They cover how the main devices work, who qualifies, and which home devices programs use.
1) What is heart failure device remote monitoring?
Heart failure device remote monitoring is the use of implanted or home devices to track early signs of worsening heart failure outside the clinic. Readings go to the care team, who can adjust treatment before symptoms lead to a hospital stay.
2) How does the CardioMEMS sensor work?
A small sensor is implanted in the pulmonary artery. Each day, the patient lies on an antenna pillow that powers the sensor and sends a pressure reading to the care team. The sensor has no battery.
3) What is the difference between CardioMEMS and Cordella?
Both measure pulmonary artery pressure. Cordella also pairs with a Bluetooth blood pressure cuff and scale, so clinicians see pressure and home vitals together. CardioMEMS is approved for NYHA class II and III patients who meet its criteria. Cordella is approved for NYHA class III.
4) Which patients qualify for an implanted pulmonary artery pressure sensor?
Under Medicare’s national coverage determination, patients need chronic heart failure for at least three months and NYHA class II or III status. They must also meet the device’s FDA indication and enroll in an approved study.
5) Can a defibrillator monitor heart failure remotely?
Some can. Certain ICD and CRT devices include algorithms such as HeartLogic or TriageHF. These combine several sensor readings and send an alert when the risk of worsening heart failure rises.
6) What home devices are used for heart failure remote monitoring?
Most programs use a connected weight scale, a blood pressure monitor, and a pulse oximeter. Daily weight is often the earliest home signal of fluid retention.
Understanding Heart Failure Device Remote Monitoring
Heart failure device remote monitoring now covers three main paths. Implanted PA sensors track pressure changes weeks before symptoms. ICD and CRT algorithms turn existing devices into early warning tools. Connected home devices give every patient a daily view of weight, blood pressure, and oxygen levels. The research supports all three, and Medicare coverage has caught up. For most programs, the right answer is a mix of tools matched to each patient.
Tenovi provides cellular-connected remote monitoring devices and the Tenovi Gateway to RPM companies, health systems, telehealth platforms, chronic care management companies, and other care organizations. Our devices need no app, no pairing, and no Wi-Fi, so patients can start sending readings on day one. Contact us for a free demo and consultation on building your heart failure monitoring program.
